Diabetic foot infections: Microbiological aspects;Le infezioni del piede diabetico: Aspetti microbiologici

Infezioni in Medicina

Volumn 20, Issue SUPP.1, 2012, Pages 20-27

  Noviello, Silvana ^a   Esposito, Isabella ^a   Pascale, Renato ^a   Esposito, Silvano ^a   Zeppa, Pio ^a  

^a UNIVERSITY OF SALERNO   (Italy)

Author keywords

Diabetic foot infections; Microbiology; S. aureus

Indexed keywords

ANTIBIOTIC THERAPY; BACTERIUM CULTURE; DIABETIC FOOT; FUNGUS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE COCCI; HOSPITALIZATION; HUMAN; INFLAMMATION; MICROBIOLOGICAL PHENOMENA AND FUNCTIONS; PREVALENCE; REVIEW; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; WOUND INFECTION;

ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; BACTERIAL INFECTIONS; CELLULITIS; DERMATOMYCOSES; DIABETIC FOOT; FOOT DISEASES; FOOT INJURIES; GANGRENE; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; PRACTICE GUIDELINES AS TOPIC; WOUND INFECTION;

EID: 84867504815     PISSN: 11249390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Caravaggi C., Piaggesi A., Menichetti F. Diabetic foot infections. Infezioni in Medicina 17, 4, 77-87, 2009.
2. Pascale R., Vitale M., Zeppa P., Russo E., Esposito S. Diabetic foot: definitions. Infezioni in Medicina 20 (Suppl 1), 5-7, 2012.
3. Repine J.E., Clawson C.C., Goetz F.E. Bactericidal function of neutrophils from patients with acute bacterial infections and from diabetes. J. Infect. Dis. 142, 869-872, 1980.
4. Geerlings S.E., Hoepelman A.I.M. Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunology and Medical Microbiology. 26, 259-265, 1999.
5. Vitale M., Zeppa P., Esposito I., Esposito S. Infected lesions of diabetic foot. Infezioni in Medicina 20 (Suppl 1), 14-19, 2012.
6. Lipsky B.A., Berendt A.R., Cornia P.B., et al. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin. Infect. Dis. 54, 12, 132-173, 2012.
7. Abbott C.A., Vileikyte L., Williamson S., Carrington A.L., Boulton A.J.M. Multicentre study of the incidence of and predictive factors for diabetic neuropathic foot ulcers. Diabetes Care. 21, 1071-1075, 1998.
8. Esposito S., Russo E., Noviello S., Leone S. Management of diabetic foot infections. Infezioni in Medicina 20 (Suppl 1), 28-34, 2012.
9. Akbari C.M., Pomposelli F.B. Jr., Gibbons G.W., et al. Lower extremity revascularization in diabetes: late observations. Arch. Surg. 135, 452-456, 2000.
10. Leone S., Pascale R., Vitale M., Esposito S. Epidemiology of diabetic foot. Infezioni in Medicina 20 (Suppl 1), 8-13, 2012.
11. Tesfaye S., Selvarajah D. Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy. Diabetes Metab. Res. Rev. 28, 1, 8-14, 2012.
12. Lo Pardo D., Pezzuti G., Selleri C., Pepe S., Esposito S. Adjuvant treatment of diabetic foot. Infezioni in Medicina 20 (Suppl 1), 35-41, 2012.
13. Cavanagh P.R., Lipsky B.A., Bradbury A.W., Botek G. Treatment for diabetic foot ulcers. Lancet 366, 1725-1735, 2005.
14. Bus S.A., Valk Gd., Deursen R.W., et al. The effectiveness of footwear and offloading interventions to prevent and heal foot ulcers and reduce plantar pressure in diabetes: a systematic review. Diabetes Metab. Res. Rev. 24, 1, 162-180, 2008.
15. Pascale R., Vitale M., Esposito S. Update on diabetic foot infections. Infezioni in Medicina 20, 4, X-Y, 2012.
16. Eneroth M., Larsson J., Apelqvist J. Foot infections in diabetes mellitus-entity with different characteristics, treatment and prognosis. J. Diabetes Complicat. 13, 254-263, 1999.
17. Lipsky B.A., Berendt A.R., Embil J., de Lalla F. Diagnosing and treating diabetic foot infections. Diabetes Metab. Res. Rev. 20, 1, 56-64, 2004.
18. Lipsky B.A., Tabak Y.P., Johannes R.S. et al. Skin and soft tissue infections in hospitalized patients with diabetes: culture isolates and risk factors associated with mortality, length of stay and cost. Diabetologia 53, 914-923, 2010.
19. Berendt A.R., Peters E.J., Bakker K., et al. Diabetic foot osteomyelitis: a progress report on diagnosis and a systematic review of treatment. Diabetes Metab. Res. Rev 24, 1, 145-161, 2008.
20. Butalia S., Palda V.A., Sargeant R.J., Detsky A.S., Mourad O. Does this patient with diabetes have osteomyelitis of the lower extremity? JAMA 299, 806-813, 2008.
21. National Institute for Health and Clinical Excellence, Diabetic foot inpatient management of people with diabetic foot ulcers and infection, 2011. Disponibile sul sito web http://guidance.nice.org.uk/CG119. 6/4/ 2011
22. Chakraborti C., Le C., Yanofsky A. Sensitivity of superficial cultures in lower extremity wounds. J. Hosp. Med. 5, 415-420, 2010.
23. Gardner S.E., Frantz R.A., Saltzman C.L., Hillis S.L., Park H., Scherubel M. Diagnostic validity of three swab techniques for identifying chronic wound infection. Wound Repair Regen.14, 548-557, 2006.
24. Powlson A.S., Coll A.P. The treatment of diabetic foot infections. J. Antimicrob. Chemother. 65, 3, 3-9, 2010.
25. Fisher T.K., Wolcott R., Wolk D.M., Bharara M., Kimbriel H.R., Armstrong DG. Diabetic foot infections: a need for innovative assessments. Int. J. Low Extrem. Wounds. 9, 31-36, 2010.
26. Sotto A., Lina G., Richard J.L., et al. Virulence potential of Staphylococcus aureus strains isolated from diabetic foot ulcers: a new paradigm. Diabetes Care 31, 2318-2324, 2008.
27. Alcalá Martínez-Gómez D., Ramírez-Almagro C., Campillo-Soto A., Morales Cuenca G., Pagán-Ortiz J., Aguayo-Albasini J.L. Infecciones del pie diabético. Prevalencia de los distintos microorganismos y sensibilidad a los antimicrobianos. Enferm. Infecc. Microbiol. Clin. 27, 317-321, 2009.
28. Citron D.M., Goldstein E.J., Merriam C.V., Lipsky B.A., Abramson M.A. Bacteriology of Moderateto-Severe Diabetic Foot Infections and In Vitro Activity of Antimicrobial Agents. J. Clin. Microbiol. 45, 2819-2828, 2007.
29. Dowd S.E., Sun Y., Secor P.R., Rhoads D.D., Wolcott B.M., James G.A., et al. Survey of bacterial diversity in chronic wounds using pyrosequencing, DGGE, and full ribosome shotgun sequencing. BMC Microbiol. 8, 43, 2008.
30. Bassetti M., Righi E., Esposito S., Petrosillo N., Nicolini L. Drug treatment for multidrug-resistant Acinetobacter baumannii infections. Future Microbiol. 6, 649-660, 2008.
31. Yates C.J., May K., Hale T., et al. Wound chronicity, inpatient care and chronic kidney disease predispose to MRSA infection in diabetic foot ulcers. Diabetes Care 32, 1907-1909, 2009.
32. Kandemir O., Akbay E., Sahin E., Milcan A., Gen R. Risk factors for infection of the diabetic foot with multi-antibiotic resistant microorganisms. J. Infect. 54, 439-445, 2007.
33. Gadepalli R., Dhawan B., Sreenivas V. A clinicmicrobiological study of diabetic foot ulcers in an Indian tertiary care hospital. Diabetes Care 8, 1727-1732, 2006.
34. Lipsky BA. Medical treatment of diabetic foot infections. Clin. Infect. Dis. 39, 2, 104-114, 2004.
35. Sotto A., Richard J.L., Combescure C., et al. Beneficial effects of implementing guidelines on microbiology and costs of infected diabetic foot ulcers. Diabetologia 53, 2249-2255, 2010.
36. Dryden M., Andrasevic A.T., Bassetti M., Bouza E., Chastre J., Cornaglia G., Esposito S., French G., Giamarellou H., Gyssens I.C., Nathwani D., Unal S., Voss A. A European survey of antibiotic management of methicillin-resistant Staphylococcus aureus infection: current clinical opinion and practice. Clin. Microbiol. Infect. 16, 3-30, 2010.
37. Gould I.M., Cauda R., Esposito S., Gudiol F., Mazzei T., Garau J. Management of serious meticillinresistant Staphylococcus aureus infections: what are the limits? Int. J. Antimicrob. Agents 37, 3, 202-209, 2011.
38. Joseph W.S., Lipsky B.A. Medical therapy of diabetic foot infections. J. Vasc. Surg. 52, 3, 67-71, 2010.
39. Sotto A., Richard J-L., Jourdan N., et al. Miniaturized oligonucleotide arrays: a new tool for discriminating colonization from infection due to Staphylococcus aureus in diabetic foot ulcers. Diabetes Care 30, 2051-2056, 2007.
40. Eleftheriadou I., Tentolouris N., Argiana V., Jude E., Boulton A.J. Methicillin-resistant Staphylococcus aureus in diabetic foot infections. Drugs 70, 1785-1797, 2010.
41. Dang C.N., Prasad Y.D., Boulton A.J., Jude E.B. Methicillin-resistant Staphylococcus aureus in the diabetic foot clinic: a worsening problem. Diabet. Med. 20, 159-161, 2003.
42. Galkowska H., Podbielska A., Olszewski W.L., et al. Epidemiology and prevalence of methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis in patients with diabetic foot ulcers: focus on the differences between species isolated from indi viduals with ischemic vs. neuropathic foot ulcers. Diabetes Res. Clin. Pract. 84, 187-193, 2009.
43. Altrichter Loan C., Legout L., Assal M., Rohner P., Hoffmeyer P., Bernard L. Infections sévères à Streptococcus agalactiae du pied diabétique. Rôle délétère du Streptococcus agalactiae? Presse Med. 34, 491-494, 2005.
44. Lipsky B.A., Armstrong D.G., Citron D.M., Tice A.D., Morgenstern D.E., Abramson M.A. Ertapenem versus piperacillin/tazobactam for diabetic foot infections (SIDESTEP): prospective, randomized, controlled, double-blinded, multicentre trial. Lancet 366, 1695-1703, 2005.
45. Dowd S.E., Wolcott R.D., Sun Y., McKeehan T., Smith E., Rhoads D. Polymicrobial nature of chronic diabetic foot ulcer biofilm infections determined using bacterial tag encoded FLX amplicon pyrosequencing (bTEFAP). PLoSOne. 2008.
46. Esposito S., Leone S., Noviello S., et al. Foot infections in diabetes (DFIs) in the out-patient setting: an Italian multicentre observational survey. Diabet. Med. 25, 8, 979-984, 2008.
47. Mlinariæ-Missoni E., Kaleniæ S., Milán V., de Syo D., Belicza M., Vaziæ-Babiæ V. Candida infections in diabetic foot ulcers. Diabetologia Croatica 34, 29-35, 2005.
48. Nair S., Peter S., Sasidharan A., Sistla S., Kochugovindan A.K. Incidence of mycotic infections in diabetic foot tissue. Journal of Culture Collections 5, 85-89, 2007.